TeraView, a pioneering tech play headquartered in Cambridge, England, will make its stock-market debut on Tuesday on this new destination for U.K. stocks and its chief executive officer, Dr. Don ...

Hong Kong's initial public offering market is gaining depth and dynamism and reinforcing its role as a premier global listing venue, with abundant liquidity, attractive valuations and market reforms ...

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

Blue Water IV is led by Joseph Hernandez, the founder of Blue Water Venture Partners and head of other SPACs under the Blue Water name. In September, his firm submitted a $10 billion offer for the ...

Collaborating with Leading and Chain Master Enterprises to Jointly Propel Hong Kong's Innovation and Technology Development ...

The ASX healthcare sector has fallen in the week ending December 5, 2025 with Epiminder down in its first week ... Read More ...

Ming Yu was set up in 2018 by Cao Guoqing, a biochemist with an international profile in cutting-edge drug research. Cao ...

The U.S. IPO market roared back in 2025, as the 176 initial public offerings during the first half of the year matched the ...

Since it’s a publicly traded company, anyone can buy Gilead Sciences stock. Here’s a step-by-step guide on how to invest money in the pharmaceutical stock: Step 1: Open your brokerage account: Log in ...

At the BIO-Europe congress in Vienna, the session titled “From Roasts to Billions: Biopharma Investment Landscape” brought ...

One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term ...

Having raised $125 million, the Cochlear-based Epiminder lists next Monday on the back of its groundbreaking epilepsy ...